413 related articles for article (PubMed ID: 28523540)
21. High frequency of copy number imbalances in Rubinstein-Taybi patients negative to CREBBP mutational analysis.
Gervasini C; Mottadelli F; Ciccone R; Castronovo P; Milani D; Scarano G; Bedeschi MF; Belli S; Pilotta A; Selicorni A; Zuffardi O; Larizza L
Eur J Hum Genet; 2010 Jul; 18(7):768-75. PubMed ID: 20125191
[TBL] [Abstract][Full Text] [Related]
22. Generation of an induced pluripotent stem cell line IGIBi18-A from an Indian patient with Rubinstein Taybi Syndrome.
Verma S; Dalabehera S; Maurya R; Singh D; Prasher B; Pandey R; Bapat S; Ramalingam S; Sachidanandan C
Stem Cell Res; 2024 Aug; 78():103456. PubMed ID: 38820863
[TBL] [Abstract][Full Text] [Related]
23. Spectrum of CREBBP mutations in Indian patients with Rubinstein-Taybi syndrome.
Sharma N; Mali AM; Bapat SA
J Biosci; 2010 Jun; 35(2):187-202. PubMed ID: 20689175
[TBL] [Abstract][Full Text] [Related]
24. Further case of Rubinstein-Taybi syndrome due to a deletion in EP300.
Foley P; Bunyan D; Stratton J; Dillon M; Lynch SA
Am J Med Genet A; 2009 May; 149A(5):997-1000. PubMed ID: 19353645
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and management in Rubinstein-Taybi syndrome: first international consensus statement.
Lacombe D; Bloch-Zupan A; Bredrup C; Cooper EB; Houge SD; García-Miñaúr S; Kayserili H; Larizza L; Lopez Gonzalez V; Menke LA; Milani D; Saettini F; Stevens CA; Tooke L; Van der Zee JA; Van Genderen MM; Van-Gils J; Waite J; Adrien JL; Bartsch O; Bitoun P; Bouts AHM; Cueto-González AM; Dominguez-Garrido E; Duijkers FA; Fergelot P; Halstead E; Huisman SA; Meossi C; Mullins J; Nikkel SM; Oliver C; Prada E; Rei A; Riddle I; Rodriguez-Fonseca C; Rodríguez Pena R; Russell J; Saba A; Santos-Simarro F; Simpson BN; Smith DF; Stevens MF; Szakszon K; Taupiac E; Totaro N; Valenzuena Palafoll I; Van Der Kaay DCM; Van Wijk MP; Vyshka K; Wiley S; Hennekam RC
J Med Genet; 2024 May; 61(6):503-519. PubMed ID: 38471765
[TBL] [Abstract][Full Text] [Related]
26. EP300 facilitates human trophoblast stem cell differentiation.
van Voorden AJ; Keijser R; Veenboer GJM; Lopes Cardozo SA; Diek D; Vlaardingerbroek JA; van Dijk M; Ris-Stalpers C; van Pelt AMM; Afink GB
Proc Natl Acad Sci U S A; 2023 Jul; 120(28):e2217405120. PubMed ID: 37406095
[TBL] [Abstract][Full Text] [Related]
27. Administration of BMP2/7 in utero partially reverses Rubinstein-Taybi syndrome-like skeletal defects induced by Pdk1 or Cbp mutations in mice.
Shim JH; Greenblatt MB; Singh A; Brady N; Hu D; Drapp R; Ogawa W; Kasuga M; Noda T; Yang SH; Lee SK; Rebel VI; Glimcher LH
J Clin Invest; 2012 Jan; 122(1):91-106. PubMed ID: 22133875
[TBL] [Abstract][Full Text] [Related]
28. Rubinstein-Taybi syndrome (CREBBP, EP300).
van Belzen M; Bartsch O; Lacombe D; Peters DJ; Hennekam RC
Eur J Hum Genet; 2011 Jan; 19(1):preceeding 118-20. PubMed ID: 20664634
[No Abstract] [Full Text] [Related]
29. Rubinstein-Taybi syndrome and CREBBP c.201 202delTA mutation: a case presenting with varicella meningoencephalitis.
Çaksen H; Bartsch O; Okur M; Temel H; Açikgoz M; Yilmaz C
Genet Couns; 2009; 20(3):255-60. PubMed ID: 19852432
[TBL] [Abstract][Full Text] [Related]
30. Rubinstein-Taybi syndrome: molecular findings and therapeutic approaches to improve cognitive dysfunction.
Hallam TM; Bourtchouladze R
Cell Mol Life Sci; 2006 Aug; 63(15):1725-35. PubMed ID: 16786226
[TBL] [Abstract][Full Text] [Related]
31. Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein-Taybi syndrome.
Kalkhoven E; Roelfsema JH; Teunissen H; den Boer A; Ariyurek Y; Zantema A; Breuning MH; Hennekam RC; Peters DJ
Hum Mol Genet; 2003 Feb; 12(4):441-50. PubMed ID: 12566391
[TBL] [Abstract][Full Text] [Related]
32. High frequency of mosaic CREBBP deletions in Rubinstein-Taybi syndrome patients and mapping of somatic and germ-line breakpoints.
Gervasini C; Castronovo P; Bentivegna A; Mottadelli F; Faravelli F; Giovannucci-Uzielli ML; Pessagno A; Lucci-Cordisco E; Pinto AM; Salviati L; Selicorni A; Tenconi R; Neri G; Larizza L
Genomics; 2007 Nov; 90(5):567-73. PubMed ID: 17855048
[TBL] [Abstract][Full Text] [Related]
33. Genotype-phenotype analysis of ocular findings in Rubinstein-Taybi syndrome - A case report and review of literature.
Jin E; Le H; Jewell A; Couser NL
Ophthalmic Genet; 2024 Feb; 45(1):51-58. PubMed ID: 37017262
[TBL] [Abstract][Full Text] [Related]
34. To learn better, keep the HAT on.
Martin KC; Sun YE
Neuron; 2004 Jun; 42(6):879-81. PubMed ID: 15207231
[TBL] [Abstract][Full Text] [Related]
35. Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome.
Murata T; Kurokawa R; Krones A; Tatsumi K; Ishii M; Taki T; Masuno M; Ohashi H; Yanagisawa M; Rosenfeld MG; Glass CK; Hayashi Y
Hum Mol Genet; 2001 May; 10(10):1071-6. PubMed ID: 11331617
[TBL] [Abstract][Full Text] [Related]
36. Germline mosaicism in Rubinstein-Taybi syndrome.
Tajir M; Fergelot P; Lancelot G; Elalaoui SC; Arveiler B; Lacombe D; Sefiani A
Gene; 2013 Apr; 518(2):476-8. PubMed ID: 23352794
[TBL] [Abstract][Full Text] [Related]
37. Two patients with EP300 mutations and facial dysmorphism different from the classic Rubinstein-Taybi syndrome.
Bartsch O; Labonté J; Albrecht B; Wieczorek D; Lechno S; Zechner U; Haaf T
Am J Med Genet A; 2010 Jan; 152A(1):181-4. PubMed ID: 20014264
[TBL] [Abstract][Full Text] [Related]
38. Aberrant forms of histone acetyltransferases in human disease.
Van Beekum O; Kalkhoven E
Subcell Biochem; 2007; 41():233-62. PubMed ID: 17484131
[TBL] [Abstract][Full Text] [Related]
39. Somatic and germ-line mosaicism in Rubinstein-Taybi syndrome.
Chiang PW; Lee NC; Chien N; Hwu WL; Spector E; Tsai AC
Am J Med Genet A; 2009 Jul; 149A(7):1463-7. PubMed ID: 19533794
[TBL] [Abstract][Full Text] [Related]
40. Transgenic mice expressing an inhibitory truncated form of p300 exhibit long-term memory deficits.
Oliveira AM; Wood MA; McDonough CB; Abel T
Learn Mem; 2007 Sep; 14(9):564-72. PubMed ID: 17761541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
